Moe, Sharon M.2019-04-192019-04-192017-07Moe S. M. (2016). Calcium as a cardiovascular toxin in CKD-MBD. Bone, 100, 94–99. doi:10.1016/j.bone.2016.08.022https://hdl.handle.net/1805/18904Disordered calcium balance and homeostasis are common in patients with chronic kidney disease. Such alterations are commonly associated with abnormal bone remodeling, directly and indirectly. Similarly, positive calcium balance may also be a factor in the pathogenesis of extra skeletal soft tissue and arterial calcification. Calcium may directly affect cardiac structure and function through direct effects to alter cell signaling due to abnormal intracellular calcium homeostasis 2) extra-skeletal deposition of calcium and phosphate in the myocardium and small cardiac arterioles, 3) inducing cardiomyocyte hypertrophy through calcium and hormone activation of NFAT signaling mechanisms, and 4) increased aorta calcification resulting in chronic increased afterload leading to hypertrophy. Similarly, calcium may alter vascular smooth muscle cell function and affect cell signaling which may predispose to a proliferative phenotype important in arteriosclerosis and arterial calcification. Thus, disorders of calcium balance and homeostasis due to CKD-MBD may play a role in the high cardiovascular burden observed in patients with CKD.en-USPublisher PolicyCalcificationCalciumChronic kidney diseaseHeartMineral bone disorderVascular smooth muscle cellsCalcium as a cardiovascular toxin in CKD-MBDArticle